Surgical resection update

Slides:



Advertisements
Similar presentations
Bristol Thoracic Surgery Unit Update What we are doing well High resection rate.
Advertisements

Resection rate for patients with tissue confirmation of NSCLC ( :England) First seen in centre with thoracic surgery? Number With a tissue diagnosis.
The Good, The Bad and The Patient Choice! Colorectal Patient Pathways Across the Network Presented by: Teresa Coombes Cancer, Oncology, Haematology and.
LUCADA Jacqueline Brown Cancer Services Manager North Tees & Hartlepool Trust.
NMDT (%)Path (%)NOS (%)CNS (%) Weston Area Health  70.5  5.7  66.3  Yeovil District Hospital  54.9  22.9  82.9  University Hospitals.
How clinicians use data to make an impact on clinical outcomes Dr Mick Peake Clinical Lead, National Cancer Intelligence Network Consultant & Senior Lecturer.
Charlie Comins 10/11/15. Bristol Experience Treated first patient in Feb 2014 Aim to treat 12 patients in first year Treated 25 patients in first 12 months.
Norwegian register for general thoracic surgery.
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
National Clinical Pathway for suspected and confirmed lung cancer:
Norwegian register for general thoracic surgery.
Oesophago–Gastric Cancer Audit
Treatment of Stage I and II Non-small Cell Lung Cancer
Brain imaging prior to lung cancer resection
How clinicians use data to make an impact on clinical outcomes
Andrew Low Respiratory Consultant BRI SWAG Lung SSG 15 November 2016
SABR Update Breast SSG June 2017.
Thoracic Surgery Update 2016
Oesophago–Gastric Cancer
HANA Audit Update for SSG
The National Optimum Lung Cancer Pathway
Jane E Scullion Respiratory Nurse Consultant
Pre-clinic information for patients
National data in thoracic surgery
Oesophago–Gastric Cancer
Outcomes from the Pulmonary Rehabilitation COPD Audit 2015
Cancer 62 day rapid recovery plan South region
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
National Optimal Lung Pathway
Cancer in Wales Population incidence of stage at diagnosis Official statistics Published 09:30 hrs 24 November
Thoracic audit update SCTS Board of Representatives
The UHBristol experience of implementing the ‘recovery package’
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Clinical activity in the last year at the BRI OG unit.
Surgical update.
Treatment of Stage I and II Non-small Cell Lung Cancer
Hannah Marder Cancer Manager UH Bristol
Results from the first National Lung Cancer Organisational Audit.
Liverpool Heart and Chest Hospital
Haematology SSG 7th November 2018
SW Alliances’ Rapid Diagnostic Pathway for Lung Cancer
Worcestershire Colorectal Cancer 2ww Pathway
National Cancer Patient Experience (NCPES) Results 2017
2018 National Mesothelioma Audit
National Cancer Patient Experience Survey
Treatment of Stage I and II Non-small Cell Lung Cancer
The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis  Pamela Samson, MD, Aalok Patel, BS,
Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival  Pamela Samson, MD, MPHS, Traves.
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
Impact of 2019 Sarcoma Service specification for Bristol
Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer  Takayuki Fukui, MD, Toshiki Okasaka, MD, Koji Kawaguchi,
Upper GI SSG Meeting Statistics
Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral?  Elliot Wakeam, MD, MPH, Joseph.
Henning A. Gaissert, MD, Felix G
Volume 155, Issue 1, Pages (January 2019)
Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.
Sian Middleton, Lead Nurse for Cancer, Gloucestershire Hospitals.
Pre-clinic information for patients
Pulmonary Resection for Lung Cancer in Octogenarians
Frailty ‘A distinctive health state related to the ageing process in which multiple body systems gradually lose their inbuilt reserves’ Fit for frailty,
MDT scorecard – using routine data to reduce unwarranted variations
Tom Bird Clinical Oncologist Bristol Haematology & Oncology Centre
National Oesophago-Gastric Cancer Audit
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
South West Lung Pathway Transformation
National data in surgery: LCCOP 2018(2016)
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Presentation transcript:

Surgical resection update Eveline Internullo SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

LCCOP 2018 (2016) SWAG Lung CAG - 21st May 2019

240 lung cancer resections 27 units 125 thoracic surgeons Median: 203 Median per surgeon: 46 Data submitted for LCCOP 2019 (2017) 240 lung cancer resections SWAG Lung CAG - 21st May 2019

Types of lung cancer operated in 2016 (LCCOP 2018) 93% NSCLC Increasing number of operations for carcinoid tumours: 87% in 2 years SWAG Lung CAG - 21st May 2019

Stages of lung cancer operated in 2016 (LCCOP 2018) 81% 12.9% SWAG Lung CAG - 21st May 2019

Types of procedure for lung cancer operated in 2016 (LCCOP 2018) 4% 77% 17% SWAG Lung CAG - 21st May 2019

Primary lung cancer resections by procedure performed 2015/6-2017/8 UHB

Procedures for primary lung cancer: proportion by VATS 2015/6-2017/8 UHB

Selected diagnostic procedures 2015/6-2017/8 UHB

Mortality for lung cancer operated in 2016 (LCCOP 2018) Survival England UHBristol 30 days 98.2% 98.1% 90 days 96.5% 97% 1 year 88.7% 88.3% SWAG Lung CAG - 21st May 2019

Mortality for lung cancer operated in 2016 SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

NLCA 2018 (2017) (unadjusted) 16.6% SWAG Lung CAG - 21st May 2019

NLCA 2018 (2017) – adjusted* resection rates Surgery - unadjusted Surgery - adjusted Alliance 16.6% 16.1% Weston 18.1% 17.5% Yeovil 14.1% 13.7% UH Bristol 19.5% 15.9% Taunton 15.6% 16.4% Bath RUH 16.3% 17.8% Gloucester 14.2% 14.7% North Bristol 18.7% 16.7% *for age, sex, stage, PS and socio-economic status SWAG Lung CAG - 21st May 2019

SWAG Lung CAG - 21st May 2019

73.5%

SWAG Lung CAG - 21st May 2019

NLCA 2018 (2017) – adjusted* resection rates Surgery - unadjusted Surgery - adjusted NCLA 2017 NCLA 2018 Alliance 13.2% 16.6% 14.9% 16.1% Weston 15.2% 18.1% 16.8% 17.5% Yeovil 15.7% 14.1% 13.7% UH Bristol 16% 19.5% 17% 15.9% Taunton 11.7% 15.6% 12% 16.4% Bath RUH 7.3% 16.3% 11.4% 17.8% Gloucester 14.2% 14.6% 14.7% North Bristol 18.5% 18.7% 17.9% 16.7% *for age, sex, stage, PS and socio-economic status SWAG Lung CAG - 21st May 2019

What next?… Surgeons’ attendance to MDTs Patients optimization for surgery - smoking cessation - COPD management - CPET - cardiology review - pulmonary rehabilitation - surgical second opinion Pathway optimization (NOLCP) - Minimize admin dead times (MDT to clinic appt) - Bundles - pooled lists - capacity (theatres, HDU) Telly link CCRM PreVid Fast Referral Forms OPA < 7 days One-stop clinic SWAG Lung CAG - 21st May 2019

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.